CKB

Oxford Population Health and SomaLogic deliver 28 million proteomic data points on China Kadoorie Biobank samples

Retrieved on: 
Monday, March 13, 2023

The SomaLogic team provided more than 28 million data points from the assay which will be combined with other available genetic, lifestyle, anthropometric and health outcome data to address a range of research questions.

Key Points: 
  • The SomaLogic team provided more than 28 million data points from the assay which will be combined with other available genetic, lifestyle, anthropometric and health outcome data to address a range of research questions.
  • Professor Zhengming Chen, Richard Peto Professor of Epidemiology at Oxford Population Health and UK-Principal Investigator of the China Kadoorie Biobank, said “The large-scale application of proteomics assays in big population biobanks such as CKB will be a game changer.
  • All participants are now being monitored for fatal and non-fatal health outcomes through linkage with established registries and health insurance databases in the study areas.
  • The project is a long-term collaboration between Oxford Population Health, Peking University and the Chinese Academy of Medical Sciences.

Distribution Agent Announces CKB168 Fair Fund

Retrieved on: 
Friday, February 3, 2023

The SEC's complaint, filed on October 9, 2013, charged 16 defendants with perpetrating a worldwide pyramid scheme from mid-2011 through October 2013.

Key Points: 
  • The SEC's complaint, filed on October 9, 2013, charged 16 defendants with perpetrating a worldwide pyramid scheme from mid-2011 through October 2013.
  • By Order entered August 25, 2022, the Court established a Fair Fund, so the civil penalties paid by the Defendants can be distributed to harmed investors.
  • To submit a Claim Form by mail, you must submit it to CKB168 Fair Fund, c/o Analytics Consulting LLC, Distribution Agent, P.O.
  • You may also call 1-855-579-3088 or email the Distribution Agent at [email protected] .

Encentive a Web3 OS Receives a Nervos Infrastructure Grant

Retrieved on: 
Tuesday, August 2, 2022

NEW YORK, Aug. 2, 2022 /PRNewswire/ -- Encentive has received a grant from the Nervos foundation to integrate Encentive's turn-key, multi-chain dApp building platform with the Nervos Layer 2 "Godwoken".

Key Points: 
  • NEW YORK, Aug. 2, 2022 /PRNewswire/ --Encentive has received a grant from the Nervos foundation to integrate Encentive's turn-key, multi-chain dApp building platform with the Nervos Layer 2 "Godwoken".
  • The Encentive Web3 OS deployment on the Ethereum-equivalent Godwoken mainnet will extend capabilities to community leaders, influencers, and enterprises who use Encentive to instantly create and customize modules for their own DeFi apps.
  • Encentive's Web3 OS capabilities include farming, staking, NFT market places, GameFi, OTC, and more.
  • The Encentive Web3 OS enables code-free overnight deployment of peer-to-peer DeFi apps and marketplaces starting from a community of one, plus fiat/crypto on/off ramps.

Inspirna Raises $50 Million in Series D Financing

Retrieved on: 
Monday, July 11, 2022

Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule therapeutics, announced that it has raised $50 million in a Series D financing round, co-led by new investors Sands Capital and Vivo Capital, with additional participation from new investor Dreavent 6.

Key Points: 
  • Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule therapeutics, announced that it has raised $50 million in a Series D financing round, co-led by new investors Sands Capital and Vivo Capital, with additional participation from new investor Dreavent 6.
  • Existing investors also participated in the financing round including Novo Holdings A/S, Sofinnova Partners, Sixty Degree Capital Fund, New York City Investment Fund LLC, Lepu Holdings, and additional investors.
  • In addition, Michael Ginder, of Sands Capital, and Jack Nielsen, of Vivo Capital, will join Inspirnas Board of Directors.
  • Inspirna identifies novel cancer targets using its microRNA-based target discovery platform, RNA-DRIVEr, which was originally developed by Inspirnas scientific co-founders at The Rockefeller University and exclusively licensed to Inspirna.

Nervos Launches Major Protocol Upgrade to Future-Proof Against Scaling Limitations

Retrieved on: 
Tuesday, May 10, 2022

NEW YORK, May 10, 2022 /PRNewswire/ -- Nervos today announced the completion of a major protocol upgrade on the Nervos Layer 1 Mainnet, which will pave the way for brand new features such as cryptographic-friendly instruction sets, virtual machine versioning, extensible block header, and new cryptography standards to improve the efficiency, capability, and smart contract composability of the ecosystem. The hard fork marks a major milestone for the development team, as it addresses current issues developers are facing, such as scaling, as well as unforeseen limitations that may occur in the future.

Key Points: 
  • Smart contract composability improvements and preparations for a light client protocol, which will improve node syncing efficiency through Flyclient capability in the future, are also included in the major protocol upgrade.
  • "With the completion of this major protocol upgrade, we're paving the way for even better network performance and experiences for our developers, dApps and partners."
  • The major protocol upgrade is part of the Nervos' continual focus on improvement as it looks to rapidly grow its dApps and project partnerships.
  • The Nervos Common Knowledge Base (CKB) is the layer 1, proof of work, public permissionless blockchain protocol of the Nervos Network.

BitWell - A Growth Asset Platform, Powerfully Breaks the Ice in a Cold Market with Over $200 Million in 24h Trading Volume

Retrieved on: 
Tuesday, March 29, 2022

Since its launch, BitWell has been committed to providing users with projects that have the most promising development and growth potential.

Key Points: 
  • Since its launch, BitWell has been committed to providing users with projects that have the most promising development and growth potential.
  • BitWell's high-quality asset selection vision is outstanding, and its performance has often been praised by users since its launch.
  • BitWell has created several asset zone such as Metaverse, NFT, GameFi, Blockchain , etc.. announcing one to several star projects for cooperation every week.
  • Currently, it has invested in Nervos (CKB), Compound, Cosmos, CELO, bybit, CoinFLEX and other crypto asset projects and trading platforms.

Ledger Rolls Out Support for CKB, the Native Token of Nervos Network

Retrieved on: 
Thursday, March 24, 2022

NEW YORK, March 24, 2022 /PRNewswire/ -- Nervos today announced that Ledger, one of the leading providers of hardware wallets, has added support for the network's native token, the Common Knowledge Byte (CKB). Starting today, Ledger users can store, send and receive CKB using their Ledger Nano X and Ledger Nano S wallets.

Key Points: 
  • Starting today, Ledger users can store, send and receive CKB using their Ledger Nano X and Ledger Nano S wallets.
  • The integration brings CKB holders easy access to Ledger, one of the most popular hardware wallet providers.
  • Hardware (or "cold") wallets like Ledger offer users full isolation between their private keys and a potentially vulnerable computer or smartphone.
  • The Nervos Common Knowledge Base (CKB) is the layer 1, proof of work, public permissionless blockchain protocol of the Nervos Network.

Nervos to Host the 'Web3 World Championship' Global Hackathon

Retrieved on: 
Friday, March 18, 2022

NEW YORK, March 18, 2022 /PRNewswire/ -- Nervos today announced the upcoming Web3 World Championship, a global hackathon aimed at highlighting, supporting, and promoting the best talents in Web3. A prize pool of $75,000 in CKB, the native token of the Nervos Network, and exclusive NFTs will be awarded to the winning individuals and teams. The hackathon will launch online March 18, 2022 at 10:00 AM ET and run through May 2, 2022.

Key Points: 
  • NEW YORK, March 18, 2022 /PRNewswire/ -- Nervos today announced the upcoming Web3 World Championship , a global hackathon aimed at highlighting, supporting, and promoting the best talents in Web3.
  • Participants are invited to become a Web3 World Champion by competing in team and solo activities, including:
    100 Meter Dash.
  • To help participants prepare for and succeed in the hackathon, Nervos will host a series of learning sessions, spaces, and live sessions.
  • The Nervos Common Knowledge Base (CKB) is the layer 1, proof of work, public, permissionless blockchain protocol of the Nervos Network.

Nervos Completes Wallet Integration to Enable Opera's Millions of Users to Send and Receive $CKB

Retrieved on: 
Tuesday, February 22, 2022

Starting today, Opera's millions of users can send and receive $CKB within the crypto wallet built into the Opera browser on Android.

Key Points: 
  • Starting today, Opera's millions of users can send and receive $CKB within the crypto wallet built into the Opera browser on Android.
  • Nervos is the newest blockchain to complete an integration with the Opera browser after Bitcoin, Ethereum, and Celo.
  • Once the next phase of integration is complete, the wallet will support token transactions on Nervos' Layer 2, Godwoken.
  • With the current integration, users across both ecosystems can begin sending and receiving $CKB tokens via Opera's built-in non-custodial wallet.

Bybit Lists Nervos CKB Perpetual Futures for Trading

Retrieved on: 
Tuesday, February 15, 2022

SINGAPORE, Feb. 15, 2022 /PRNewswire/ -- Bybit , a popular platform for crypto lovers around the globe, has listed CKByte ($CKB), the native token of the Nervos Network , for perpetual futures trading.

Key Points: 
  • SINGAPORE, Feb. 15, 2022 /PRNewswire/ -- Bybit , a popular platform for crypto lovers around the globe, has listed CKByte ($CKB), the native token of the Nervos Network , for perpetual futures trading.
  • Bybit is the first trading platform to list $CKB perpetual futures.
  • Unlike a typical futures contract, perpetual swaps don't have an expiration date, eliminating the need to consistently reestablish a long or short position.
  • The Nervos Common Knowledge Base (CKB) is the layer 1, proof of work, public permissionless blockchain protocol of the Nervos Network.